| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN)
BHVN Technical Analysis
5
| As on 8th May 2025 BHVN STOCK Price closed @ 20.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 42.26 & Strong Sell for SHORT-TERM with Stoploss of 40.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BHVNSTOCK Price
| Open | 19.30 | Change | Price | % |
| High | 21.07 | 1 Day | 1.23 | 6.47 |
| Low | 18.77 | 1 Week | -1.63 | -7.45 |
| Close | 20.25 | 1 Month | -8.61 | -29.83 |
| Volume | 1903235 | 1 Year | -10.35 | -33.82 |
| 52 Week High 59.75 | 52 Week Low 16.54 | ||||
NYSE USA Most Active Stocks
| FSR | 0.02 | 0.00% |
| DDR | 15.44 | -4.46% |
| BBD | 2.70 | 18.94% |
| TWTR | 53.70 | 0.66% |
| PLTR | 119.15 | 7.85% |
| SWN | 7.11 | -0.56% |
| F | 10.28 | 0.00% |
| BACA-U | 302.00 | 0.67% |
| ENLC | 14.12 | -0.21% |
| HIMS | 51.40 | -1.81% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| BHVN Daily Charts |
BHVN Intraday Charts |
Whats New @ Bazaartrend |
BHVN Free Analysis |
|
|
BHVN Important Levels Intraday
| RESISTANCE | 24.68 |
| RESISTANCE | 23.26 |
| RESISTANCE | 22.38 |
| RESISTANCE | 21.50 |
| SUPPORT | 19.00 |
| SUPPORT | 18.12 |
| SUPPORT | 17.24 |
| SUPPORT | 15.82 |
BHVN Forecast May 2025
| 4th UP Forecast | 52.2 |
| 3rd UP Forecast | 41.95 |
| 2nd UP Forecast | 35.62 |
| 1st UP Forecast | 29.29 |
| 1st DOWN Forecast | 11.21 |
| 2nd DOWN Forecast | 4.88 |
| 3rd DOWN Forecast | -1.45 |
| 4th DOWN Forecast | -11.7 |
BHVN Weekly Forecast
| 4th UP Forecast | 28.83 |
| 3rd UP Forecast | 26.08 |
| 2nd UP Forecast | 24.38 |
| 1st UP Forecast | 22.68 |
| 1st DOWN Forecast | 17.82 |
| 2nd DOWN Forecast | 16.12 |
| 3rd DOWN Forecast | 14.42 |
| 4th DOWN Forecast | 11.67 |
BHVN Forecast2025
| 4th UP Forecast | 109.7 |
| 3rd UP Forecast | 81.01 |
| 2nd UP Forecast | 63.28 |
| 1st UP Forecast | 45.55 |
| 1st DOWN Forecast | -5.05 |
| 2nd DOWN Forecast | -22.78 |
| 3rd DOWN Forecast | -40.51 |
| 4th DOWN Forecast | -69.2 |
Biohaven Pharmaceutical Holding Company Ltd ( NYSE USA Symbol : BHVN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BHVN Business Profile
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut. Address: 215 Church Street, New Haven, CT, United States, 06510
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service